MIRA Pharmaceuticals, Inc. Share Price & Technical Analysis
MIRA · $0.99 (+1.02%)
Healthcare / Drug Manufacturers - General
$0.99
+1.02%
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical mari…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 4 years shown)
0% return in May, 3% avg return in past 3 year May month.
-29% return in 2026, 54% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -20% | 8% | -8% | -9% | 0% | – | – | – | – | – | – | – | -29% |
| 25 | 0% | -17% | 0% | 20% | 17% | -8% | 33% | -12% | 0% | 31% | -6% | 7% | 65% |
| 24 | -18% | 11% | 10% | -18% | -11% | -25% | 250% | -10% | -32% | 69% | -41% | -15% | 170% |
| 23 | – | – | – | – | – | – | – | -10% | -25% | -60% | 94% | -72% | -74% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$41.90M
P/E ratio
—
52W high
$2.45
52W low
$0.90
Volume
34,629
Beta
1.50
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is MIRA Pharmaceuticals, Inc. share price today?
- MIRA Pharmaceuticals, Inc. (MIRA) last traded around $0.99 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MIRA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MIRA. Download the app for real-time alerts.
- How can I analyze MIRA Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.